ESTRO35 Programme Book

ELECTRONIC POSTERS

> Long term patient reported urinary function following external beam radiotherapy for prostate cancer S. Chin (Australia), A. Hayden, V. Gebski, S. Cross, S. Turner > Consistency of cone beam CT-derived bladder volume and inflow during localized prostate cancer IMRT C.J. HO (UK), C.K. McGarry, J.Y. Sun, C.A. Lyons, R.B. King, S. Jain, A.R. Hounsell, J.M. O’Sullivan > Should pelvic radiotherapy be tailored to early patient-reported gastrointestinal toxicity? M. Reis Ferreira (UK), S. Gulliford, K. Thomas, L. Truelove, H. McNair, D.P. Dearnaley > SBRT in the treatment of bone metastases in hormone refractary prostate cancer S. Grespi (Italy), C. Menichelli, A. Fanelli, P. Ferrazza, G. Pastore, F. Casamassima > Primary focal prostate radiotherapy: do all patients really need whole- prostate irradiation? B.A. Jereczek-Fossa (Italy), D. Ciardo, G. Petralia, M. Bellomi, O. De Cobelli, R. Orecchia > ADC of prostate tumour and normal tissue during radiotherapy after neoadjuvant hormone therapy L. Kershaw (UK), A. McPartlin, A. Choudhury, M. Van Herk > PET/CT and MRI guided salvage radiotherapy after prostatectomy for prostate cancer S. Kirste (Germany), J. Bons, N. Volegova-Neher, C. Zamboglou, K. Henne, W. Schultze-Seemann, H.C. Rischke, A.L. Grosu > PSA kinetics in prostate cancer patients after SBRT radiotherapy using CyberKnife. M. Konkol (Poland), A. Galuba, P. Milecki, A. Skrobala, A. Jodda, M. Adamczyk, J. Litoborska > Acute toxicity hypofractionated-IMRT vs standard radiotherapy in prostate cáncer: comparative study J. Valero Albarran (Spain), R. Guimaraes Domingos da Silva, S. Payano, A. Montero, E. Sánchez, X. Chen, O. Hernando, M. García Aranda, R. Ciervide, M. Lopez, M. Rubio

EP-1376

EP-1377

EP-1378

EP-1379

EP-1380

EP-1381

EP-1382

EP-1383

EP-1384

POSTERS AND ELECTRONIC POSTERS | PROGRAMME AND EXHIBITION GUIDE

251